نتایج جستجو برای: seroprotection

تعداد نتایج: 374  

2013
Alastair J. Moss Fiona P. Gaughran Aliyye Karasu Anthony S. Gilbert Alex J. Mann Colin M. Gelder John S. Oxford Henry A. Stephens Rob Lambkin-Williams

Influenza is a major cause of morbidity and mortality. Despite vaccination, many elderly recipients do not develop a protective antibody response. To determine whether Human Leukocyte Antigen (HLA) alleles modulate seroprotection to influenza, a cohort of HLA class II-typed high-risk vaccine recipients was investigated. Haemagglutinin inhibition (HAI) titres were measured 14-40 days post-subuni...

Journal: :Hong Kong medical journal = Xianggang yi xue za zhi 2012
K M Chow S H K Lo C C Szeto S K Yuen K S Wong B C H Kwan C B Leung P K T Li

1. The response rate to recombinant hepatitis B vaccine was suboptimal (70.1%) in the peritoneal dialysis population. 2. We investigated whether a three-dose regimen of extrahigh dose (80 μg) of Engerix-B would achieve a higher rate of primary seroconversion and more persistent seroprotection in peritoneal dialysis patients, compared with the conventional 40-μg dose. 3. The rates of seroconvers...

Journal: :hepatitis monthly 0
mehran karimi children growth disorders research center, shahid sadoughi university of medical science, ir iran ali raee department of pediatrics, shahid sadoughi university of medical science, ir iran behnam baghianimoghadam research and clinical center for infertility,,sjo}iel{aeuolisunimw{ity of medical science, ir iran +98-3518247085-6, [email protected]; research and clinical center for infertility,,sjo}iel{aeuolisunimw{ity of medical science, ir iran +98-3518247085-6, [email protected] mohammad hossein fallahzadeh department of biostatistics, shahid sadoughi university of medical sciences, ir iran

background malnutrition is the most common cause of immune deficiency. it results in reduced secretion of t-cells and b-cell-stimulating factors leading to declining of special immunoglobulins. on the other hand, hepatitis b, as a major world health problem, can be prevented effectively by vaccination. three doses of hepatitis b virus (hbv) vaccine induce protective levels of anti-hepatitis b s...

Journal: :Journal of infection in developing countries 2014
Adib Rodriguez Solares Carlos Grazioso Aragon Rodolfo Urruela Pivaral David Prado-Cohrs Victor Sales-Carmona Michele Pellegrini Nicola Groth

INTRODUCTION The efficacy of non-adjuvanted seasonal influenza vaccine in young children is considered to be suboptimal. This study compared the safety and immunogenicity profiles of MF59-adjuvanted, trivalent, influenza vaccine (ATIV) and non-adjuvanted, trivalent, influenza vaccine (TIV) in Guatemalan children (N = 360) between 6 and < 60 months of age. METHODOLOGY Children received two dos...

Journal: :Saudi Journal of Kidney Diseases and Transplantation 2017

Journal: :Vaccine 2006
Katherine Goodwin Cécile Viboud Lone Simonsen

We performed a quantitative review of 31 vaccine antibody response studies conducted from 1986 to 2002 and compared antibody responses to influenza vaccine in groups of elderly versus younger adults. We did a weighted analysis of the probability of vaccine response (measured as seroconversion and seroprotection) for each vaccine component (H1, H3 and B antigens). Using a multiple regression mod...

Journal: :Clinical and vaccine immunology : CVI 2013
Timo Vesikari Sven Arne Silfverdal Florence Boisnard Stéphane Thomas Grace Mwawasi Donna Reynolds

This study compared the levels of immunogenicity and safety of diphtheria-tetanus toxoid-five-component acellular pertussis (DTaP(5)), inactivated poliovirus (IPV), and Haemophilus influenzae type b (Hib) (DTaP(5)-IPV-Hib) and DTaP(3)-IPV/Hib vaccines for study participants 3, 5, and 12 months of age. Post-dose 3 noninferiority criteria comparing DTaP(5)-IPV-Hib to DTaP(3)-IPV/Hib using rates o...

Journal: :The Journal of infectious diseases 2015
Xue-en Liu Hai-ying Chen Zheng Liao Yisheng Zhou Hairong Wen Shihui Peng Yan Liu Rui Li Jie Li Hui Zhuang

UNLABELLED A randomized clinical trial of hepatitis A vaccines (1 or 2 doses of inactivated vaccine [Healive] or 1 dose of live attenuated vaccine [Biovac]) was conducted among adults to evaluate seroprotection rates and geometric mean concentrations of antibody against hepatitis A virus for 36 months. High rates of seroprotection persisted for at least 36 months among adults who received 1 or ...

Journal: :Journal of Crohn's & colitis 2014
C Loras J P Gisbert M C Saro M Piqueras C Sánchez-Montes J Barrio I Ordás A Montserrat R Ferreiro Y Zabana M Chaparro F Fernández-Bañares M Esteve

AIMS Assess IBD patients starting anti-TNF for the impact of preventive measures in HBV and/or HCV, and the predictive response factors to HBV vaccination. METHODS Multicenter prospective study including 389 IBD patients. Four interventions were established: I-1) anti-HBs <100IU/L: HBV vaccination with double doses at 0-1-2months, and revaccination if titres <100IU/L (seroprotection defined a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید